Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temporal Dynamics and Pharmacokinetics of Intranasally Administered Oxytocin
NCT03011970Phase 1Completed
- Sponsor
- University Hospital Bonn
- Start
- Sep 2014
- Primary completion
- Dec 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1 trial of oxytocin in Autism Spectrum Disorder (ASD) (6 arms), sponsored by University Hospital Bonn. Primary endpoint: Neural substrates of emotion processing, measured via blood-oxygen-level dependent signal in the amygdala. Started Sep 2014; status: completed.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03011970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03011970.